Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

Drug Policy

RainDog

(28,784 posts)

1. oh yeah

Reply to RainDog (Original post)

Wed Jan 4, 2012, 11:31 PM

Jan 2012

the way in which GW Pharma wants to make it possible to market Sativex or the cancer pain med they now have in the last phases of clinical trial is to grow the cannabis in Japan.

This is part of their partnership with Otsuka Pharmaceutical, in Japan.

iow, GW hopes to suck the dick of the DEA and get a favorable ruling by outsourcing the production of cannabis to Japan when the U.S., Canada and The Netherlands have been the leaders in cannabis horticulture for the last twenty years.

If you're not outraged - you're complicit in this bullshit.

Edit history

Please sign in to view edit histories.

4 replies

= new reply since forum marked as read

Highlight:

Sativex revenues for 2011: £29.6 million [View all] RainDog Jan 2012 OP

oh yeah RainDog Jan 2012 #1

Why is it bad for cancer patients to feel euphoria? tridim Jan 2012 #2

Puritanism: The haunting fear that someone, somewhere, may be happy. H.L. Mencken RainDog Jan 2012 #3

Andrea Barthwell: Deputy Drug Czar turned lobbyist for Bayer/GW Pharma/Sativex RainDog Jan 2012 #4